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Myoclonus-dystonia (M-D) is a movement disorder characterized by rapid muscle contractions and sustained
twisting and repetitive movements and has recently been associated with mutations in the e-sarcoglycan gene
(SGCE). The mode of inheritance is autosomal dominant with reduced penetrance upon maternal transmission,
suggesting a putative maternal imprinting mechanism. We present an apparently sporadic M-D case and two patients
from an M-D family with seemingly autosomal recessive inheritance. In both families, we detected an SGCEmutation
that was inherited from the patients’ clinically unaffected fathers in an autosomal dominant fashion. Whereas, in
the first family, RNA expression studies revealed expression of only the mutated allele in affected individuals and
expression of the normal allele exclusively in unaffected mutation carriers, the affected individual of the second
family expressed both alleles. In addition, we identified differentially methylated regions in the promoter region of
the SGCE gene as a characteristic feature of imprinted genes. Using a rare polymorphism in the promoter region
in a family unaffected with M-D as a marker, we demonstrated methylation of the maternal allele, in keeping with
maternal imprinting of the SGCE gene. Loss of imprinting in the patient with M-D who had biallelic expression
of the SGCE gene was associated with partial loss of methylation at several CpG dinucleotides.
Introduction
Myoclonus-dystonia (M-D [MIM 159900]) is a move-
ment disorder characterized by a combination of rapid,
brief muscle contractions (myoclonus) and sustained
twisting and repetitive movements, resulting in abnormal
postures (dystonia). M-D usually starts in the 1st or 2nd
decade of life and is usually inherited in an autosomal
dominant fashion. Males and females are equally affected
(Gasser 1998; Klein 2002). A major M-D gene was lo-
cated on chromosome 7q21 in the majority of tested fam-
ilies (Nygaard et al. 1999; Klein et al. 2000; Asmus et al.
2001; Vidailhet et al. 2001) and was recently identified
as the e-sarcoglycan gene (SGCE [GenBank accession
number NM_003919; MIM 604149]), with five different
heterozygous loss-of-function mutations in six German
families with M-D (Zimprich et al. 2001).
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The function of the SGCE protein, a transmembrane
glycoprotein, is still elusive in this context of a non-
degenerative movement disorder of the CNS. The other
members of the sarcoglycan family—a-, b-, g-, and d-
sarcoglycan—compose a complex that is an important
structure of dystrophin-associated glycoprotein assem-
bly in striated muscles.
The murine Sgce gene is primarily transcribed from the
paternal allele and is therefore maternally imprinted
(Piras et al. 2000). Interestingly, pedigree analysis of sev-
eral families with M-D showed a marked difference in
penetrance, depending on the parental origin of the dis-
ease allele. This indicated a putative maternal imprinting
mechanism in humans, as well, that may be responsible
for the reduced penetrance of the condition in individuals
who inherited the mutated allele from their mother (Zim-
prich et al. 2001).
Genomic imprinting is defined as the epigeneticmark-
ing of certain subregions of the parental genome in
mammals, resulting in the expression of imprinted genes
of one allele only, according to their parent of origin
(Reik and Walter 2001). Genomic imprinting requires
an epigenetic control mechanism, such as differential
methylation of CpG dinucleotides depending on their
parental origin (Razin and Cedar 1994). Here we pre-
sent the clinical and genetic analysis of two families with
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66 35 376PromUR CAGCTCATGTACCTCTGCAGTTC
Exon 1:
Ex 1 F CTGATGCTGAACTGGCCAAG
60 35 304Ex 1 R AGAGAGGCTGGTGCCCAAAG
Exon 2:
Ex 2 Fs CTGAATTATCAAGGGCGTATC
56 35 295Ex 2 Rs CCATTTGAAATAATGTTAATG
Exon 3:
Ex 3 Fs AGACAGAATGTTTTGATTGAAAC
60 35 355Ex 3 Rs ACCACCATCAGGTAAGTTTAG
Exon 4:
Ex 4 F TTCTCATTGCCCAGAGAAGG
58 35 339Ex 4 R TCAGTTATATTAGGTATGTGGC
Exon 5:
Ex 5 Fs CTTCATTAAAGATATGCATGC
58 35 306Ex 5 Rs ATAAGTTTGATAAGATCACCG
Exon 6:
Ex 6 Fs TAAATCCTGCTTTTAAGGTGG
58 35 335Ex 6 Rs TTATTCCTAAAAGCAGTTCAG
Exon 7:
Ex 7 F AAGAATGCTTTAGTGTATCCAG
58 35 348Ex 7 Rs TTGTTATCTTAGCAGGATCTC
Exon 8:
Ex 8 F GACAATGTCAGCATTTCCAC
58 35 309Ex 8 R GTTTTAGTTTCTACCCCTCCT
Exon 9:
Ex 9 F CAAATTGATGACCCATCAGGC
60 35 295Ex 9 Rs CATGCATATTAATAATTATGGCTC
Exon 10:
Ex10 Fs TAATGTAGCCTAGTGGCCAC
55 40 448Ex10 Rs AGCCAACTTCATGACTTCTAG
Exon 11:
Ex 11 F CTGGGGTCATAGTTTACCCG
60 35 249Ex11 Rs ATTTGGTGAAGATAAAGCTTC
Exon 12:
Ex 12 F GATGGAAACTTTCTCCTTGCC
60 35 230Ex 12 R CAACATGCATAACATATGCCAG
3′ UTR:
3UTR F TGCTCAAAATCTAAAAGTATCCAT
55 35 3723UTR R ATTTCACCAGTCATTAGGCTTCA
M-D with novel SGCE mutations and provide molec-
ular evidence for paternal expression of the SGCE gene,
by means of cDNA analysis and bisulfite sequencing.
Subjects and Methods
Subjects
All patients and unaffected family members underwent
a standardized neurological examination performed by a
movement-disorders specialist. The diagnosis ofM-Dwas
established according to the recently modified clinical cri-
teria (Gasser 1998; Klein 2002). In family V, the mode
of inheritance appeared to be recessive, with two affected
sisters from unaffected parents, and the patient in family
S seemed to have a sporadic case of the disorder.
Mutation Analysis
After obtaining informed consent, we collected a blood
sample from each available member of families V and S,
and both DNA and RNA were extracted directly from
the blood. All 12 exons and flanking intron regions of
the SGCE gene were tested for mutations by means of
SSCP analysis, followed by cycle sequencing of PCRprod-
ucts in cases of observed band shifts, through use of an
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3Fi (3 forward) GCGAGATTAGTAATGATCCC
58 30 8057Ri (7 reverse) ACGCCTTCCCGTCGGCAGCAC
4Fi (4 forward) AACTGCCTACAACAGGCGCAC
58 30 4336Ri (6 reverse) CAATGAAATTTTGCACCAGTC
5Fi (5 forward) CGTTGCCATATCAAGCAGAATTC
58 30 7769RiE (9 reverse) TGCATCAATGGCATGTTTGTG
6Fi (6 forward) GATGTAGTCAAGAAATGGAGC
58 30 3619RiA (9 reverse) GATTTCTGAATAGCACTGTGATG
automated sequencing machine (LI-COR). In addition,
100 chromosomes from both unrelated patients with
M-D and unaffected control individuals were screened for
the presence of exonic polymorphisms in the coding re-
gion of the SGCE gene, by SSCP. Furthermore, we
screened 44 individuals from 20 families by sequencing,
as well as 242 control chromosomes of unrelated indi-
viduals by SSCP analysis, for the presence of three known
polymorphisms in the promoter region (911GrC,
1062GrA, and 1067ArG [Grabowski et al. 2002]).
Finally, 260 control chromosomes from individuals of
central European origin were investigated for the presence
of sequence changes in the 3′ UTR, by SSCP analysis.
Primers and PCR conditions are summarized in table 1.
cDNA Analysis
For cDNA analysis, we reverse transcribed RNA from
all available family members, through use of random
primers (SuperScript; Invitrogen). To amplify mutation-
containing regions, we employed a nested PCR assay,
using primers shown in table 2, followed by direct cycle
sequencing of the amplicons. In addition, a melting-
curve analysis of PCR products was performed with spe-
cific mutation-sensitive hybridization probes on the
LightCycler (Roche Diagnostics) (table 3). In exon 5, the
hybridization probes were complementary to the wild-
type sequence, and, thus, the melting temperature of the
probe-target hybrid was lower for the mutant allele (mis-
match). For exon 7, the hybridization probes were de-
signed to be complementary to the mutant sequence,
resulting in a higher melting temperature of the probe-
target hybrid of the mutant allele (perfect match). For
visualization of the melting temperatures as a peak, the
software took the first negative derivative (dF/dT) of
the melting curve.
Bisulfite Sequencing
By bisulfite treatment of genomic DNA (gDNA), all
unmethylated cytosine residues are converted to uracil,
while methylated residues remain unaltered in this pro-
cess. After subsequent methylation-specific PCR (MSP)
and sequencing, all unmethylated cytosine residues ap-
pear as thymidines in the sequence. Bisulfite treatment
of gDNA was performed using a protocol based on that
of Frommer et al. (1992). In brief, 2 mg of DNA were
alkaline denatured and treated overnight (for 16 h) with
hydrochinone (500 mM) and sodium bisulfite (2.6 M).
For desalting and the final desulfonation reaction, we
used the CpGenome DNA Modification Kit (Intergen).
Bisulfite-treated DNA was dissolved in 35 ml of 10-mM
Tris-HCl (pH 8.0).
MSP was performed using Taq polymerase and the
primers listed in table 4. PCR products were visualized
on ethidium bromide–stained agarose gels and were ex-
tracted using Perfectprep Gel Cleanup (Eppendorf). PCR
products were cloned in the pCR2.1Topo vector, through
use of Topoisomerase (Topo TA-Cloning Kit; Invitrogen)
to separate the parental alleles. PCR product–containing
plasmids were isolated using the QIAprep Spin Miniprep
Kit (Qiagen) and were sequenced using vector-specific
primers (table 4).
Genotyping
Haplotype analysis of the SGCE region on chromo-
some 7q was performed with the following polymorphic
DNAmarkers (marker positions are given in parentheses):
D7S2212 (95.43 cM), D7S2410 (100.81 cM), D7S1820
(105.92 cM), Col1A2mfd (106.46 cM), Col1A2 (106.46
cM), D7S2482 (108.59 cM), and S7S821 (109.12 cM)
(Center for Medical Genetics Web site).
Results
Patients
In both families, the affected individuals showed char-
acteristic clinical signs of M-D. Ages at onset for the
three affected females were 4 and 9.5 years (family V)
and 2 years (family S). All three patients showed typical
myoclonus and dystonia.
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gDNA cDNA gDNA cDNA
SGCE 5F (4, 5 forward) TTAATATAATGTCTGCAGAAGACT
57 30 285SGCE 5R (6 reverse) TGTGGATTTTCAACTTCTCGTA
SGCE 5 Sensor [A] (5) CCCTGCCACCCCTGTCTAG-F
63.8 63.5 60.2 58.4SGCE 5 Anchor (5) L-CCGATGTGATGTTTATGGCGTTCAG-P
SGCE 7F (6, 7 forward) GGTGCAAAATTTCATTGGTTG
57 30 191SGCE 7R (7 reverse) GACCAGTGCCACTGCCGA
SGCE sensor delT (7) L-TCCTAATTACACTGGC_GTGCC-P
58.3 59.3 63.1 64.8SGCE 7 anchor (7) TTCTTTGAAAAGCAGAGACTATTACACGGA-F
a Sequences of primers and FRET hybridization probes used for the melting analysis of gDNA and mRNA (cDNA). The sensor probe for
exon 5 is in the sense orientation and is wild-type–specific [A], and the sensor probe for exon 7 is in the antisense orientation and is mutant-
specific [delT]. The sites of the mutations are underlined. “F” indicates a 3′-terminal fluorescein-label (donor dye), “L” is the 5′-terminal acceptor
dye (LightCycler Red 640; Roche Diagnostics), and “P” is a 3′-terminal phosphate group preventing polymerase probe extension.
Mutations in the SGCE Gene
In family V, we detected a 1-bp deletion in exon 7
(966delT) (fig. 1B.1), resulting in frameshift at amino
acid 322 and protein truncation at position 333. In fam-
ily S, we found a 1-bp insertion in exon 5 (625insG),
resulting in a missense protein from amino acid 210
onward, with protein truncation after position 216 (fig.
1B.2).
mRNA Expression Studies
At the cDNA level, sequence analysis revealed only
one expressed allele in the mutation carriers in family
V. The affected individuals expressed only the mutated
allele, whereas the unaffected father expressed only the
wild-type allele (fig. 1B.1). These results were confirmed
by melting-curve analysis: the unaffected mutation-neg-
ative mother showed one melting-temperature peak at
the gDNA level, whereas all three mutation carriers had
two melting-temperature peaks, indicative of both the
mutated and the wild-type alleles (fig. 1C.1a). At the
cDNA level (fig. 1C.1b), both affected children had only
the high melting-temperature peak (i.e., the mutated al-
lele), whereas their parents had the low melting-tem-
perature peak, corresponding to the wild-type allele.
In family S, the mutation-carrying father also ex-
pressed only the normal allele, whereas the affected
daughter showed expression of both parental alleles, as
shown by two different approaches (cDNA sequencing
[fig. 1B.2] and melting-curve analysis [fig. 1C.2]). Con-
tamination with gDNA was excluded through use of an
exon-spanning nested PCR assay, and all experiments
were performed in triplicate, with the same results. No
other mutations were found in the coding region of the
SGCE gene of the affected daughter in family S.
Search for Polymorphisms
One of 20 families unaffected with M-D (family R)
carried the 1067ArG polymorphism in the promoter
region. In this family, the mother and the elder daughter
were heterozygous for the polymorphism (A/G), whereas
the father and the younger daughter were homozygous
for the wild-type allele (A/A) (fig. 2). The same poly-
morphism was detected by SSCP analysis in 7 of 121
unrelated individuals, for whom no relatives were avail-
able. Neither of the two other known polymorphisms
in the promoter region was detected in any individual
studied. Also, we did not identify any polymorphisms
in the transcribed regions of SGCE, including the exons
and the 3′ UTR.
Imprinting Studies
Through bisulfite sequencing of the PromM region
(nucleotide positions1148 to773 relative to the start
ATG), we identified a total of 25 methylated cytosines
at all CpG dinucleotides in a 376-bp part of the pro-
moter region of the SGCE gene. These methylated cy-
tosines were present on one parental allele only (fig. 2B).
Using a polymorphism in the same region, we demon-
strated in family R (which was unaffected with M-D)
that the maternal allele, marked by the polymorphism
(G), was methylated in 5/5 clones. In contrast, the pa-
ternal allele, as indicated by the wild-type A, was un-
methylated (all cytosines converted to thymidine) in an-
other 5/5 clones (fig. 2B). Thus, in this family, all of the
maternal CpG dinucleotides were methylated in the re-
gion studied, whereas none of the paternal CpG dinu-
cleotides was methylated (table 5).
Since we observed biallelic expression of the SGCE
gene in the affected members of family S, we performed
imprinting studies on this family, as well. The index pa-
tient also showed completely methylated (14/24 clones)
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MSP Primers and Primers for Plasmid Sequencing











PromMF (promoter SGCE) GTGTTATGTTTTATAAATAGATAAG
59 35 376PromMR (promoter SGCE) CAACTCATATACCTCTACAATTC
Imp3F (promoter SGCE) TTTGTTTTGGGGTATAGTTAGTGAAG
57 35 392Imp3R (promoter SGCE) ATACAACCTATATAAAACTCTCAATC
M13 F (plasmid) CACGACGTTGTAAAACGAC
60 35 227  insertM13 R (plasmid) GGATAACAATTTCACACAGG
and completely unmethylated (5/24 clones) alleles in the
studied PromM region. In addition, we found hypo-
methylated alleles in 5/24 clones. The PromM PCR-
product inserts contained 1 (twice), 3, 7, or 21 converted
Cs, indicating that these CpG dinucleotides were un-
methylated (table 5; example shown in fig. 2C). Simi-
larly, another region of the promoter (Imp3) that is even
closer to the translational start site (nucleotide positions
625 to 234 relative to the start ATG) also showed
completely methylated (2/8 clones), completely unmeth-
ylated (2/8 clones), and hypomethylated (4/8 clones) al-
leles. The Imp3 region contained 28 differentially meth-
ylated CpG dinucleotides. Hypomethylated clones had
1, 2, 24, or 26 converted Cs (data not shown). The
converted Cs appeared to be randomly spread over both
regions studied. Unfortunately, parental origin of the al-
leles could not be determined, because of the lack of
polymorphisms in family S.
Analysis of the methylation pattern in the father of
this family, who showed expression of the wild-type al-
lele only, revealed completely methylated (6/11) and
completely unmethylated (5/11) alleles for the PromM
region (table 5). In contrast, the mother had completely
methylated (6/24), completely unmethylated (8/24), and
hypomethylated (10/24) alleles in the same region (table
5). As in the daughter, hypomethylation occurred at ran-
dom positions and variable frequencies (1 [three times],
2 [twice], 22, and 24 [four times] converted Cs in the
10 hypomethylated clones).
In addition, we found a few single-base-pair substitu-
tions, at random positions in the inserts of all plasmids
sequenced, that were generated from three different in-
dividuals with and withoutM-D. These sequence changes
are most likely due to errors introduced by the Taq poly-
merase. We calculated the error rate for the Taq and the
conditions used as 1:800 (0.13%).
Haplotype Analysis
In both families with M-D, affected individuals in-
herited the mutation-bearing allele from their unaffected
fathers in an autosomal dominant fashion, as demon-
strated by haplotype analysis (fig. 1A.1 and 1B.1). In
family R (not affected with M-D), paternity was con-
firmed by haplotype analysis (fig. 2A).
Discussion
In both families withM-D, we identified novelmutations
in the recently identified SGCE gene (Zimprich et al.
2001) and demonstrated autosomal dominant inheri-
tance of these mutations in a putative sporadic case and
in a family with a proposed recessive mode of inheri-
tance. Pseudosporadic or pseudorecessive inheritance
could be explained by reduced penetrance. In both fam-
ilies, the father carried the mutated allele but was clin-
ically unaffected because he expressed only the wild-type
copy while the mutated allele was silent. Interestingly,
reduced penetrance of the disorder is found particularly
in the offspring of affected women, as observed in clin-
ical-genetic pedigree analyses (Zimprich et al. 2001). To
explain this phenomenon, a possible maternal imprint-
ing mechanism was proposed that leads to paternal ex-
pression of the mutated allele only (Zimprich et al.
2001). As shown in other imprinted disorders, imprinted
mutations can be silently transmitted for generations un-
til they are passed through the “expressing” parental sex
to the affected offspring (Viljoen and Ramesar 1992). It
is likely that the fathers from families V and S inherited
the mutated alleles from their mothers, who were not
available for molecular genetic studies.
Paternal Expression of the Human SGCE Gene
in Family V
This is the first report, to our knowledge, of molecular
evidence of paternal expression of the human SGCE
gene. As demonstrated by cDNA sequencing and melt-
ing-curve analysis, both daughters from family V ex-
pressed only the paternal, mutated allele and were there-
fore clinically affected.
Figure 1 Pedigrees of families V and S. A.1 and A.2, Pedigrees with haplotypes in the SGCE region on chromosome 7q21. Affected
individuals are shaded in black; unaffected mutation carriers are indicated with a black dot. The mutated allele inherited from each of the
fathers is highlighted in gray. B.1 and B.2, Sequences at the gDNA and cDNA levels, with the 966delT in exon 7 and 625insG in exon 5
(reverse strand is shown) indicated with arrows. C.1 and C.2, Melting curves generated with gDNA (a) and cDNA (b).
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Figure 2 Methylation studies. A, Pedigree of family R, with haplotypes in the SGCE chromosomal region. B, Sequences of two plasmids
containing either the paternal (left) or maternal (right) allele of individual II.1 from family R, after bisulfite treatment. The polymorphism
is indicated with an arrow. Sequences demonstrate that the maternal allele (with G) was methylated, since several Cs (indicated by asterisks)
escaped conversion to Ts. In contrast, the paternal allele was unmethylated. C, Sequence of plasmid 5 of the PromM region derived from
the index patient in family S, demonstrating the loss of two methylated Cs (indicated by triangles).
Maternal Imprinting of the Human SGCE Gene
Methylation of CpG dinucleotides correlates with
transcriptional repression of genes, including imprinted
genes. Mechanisms for imprinting include differentially
methylated regions (DMRs) of promoters and of im-
printing-control regions (Reik and Murrell 2000). By
investigating a part of the promoter region of the human
SGCE gene, we identified such DMRs. A polymorphism
in family R served to distinguish the parental alleles after
cloning and demonstrated that the maternal allele is
methylated. This is indicative of silencing of this allele,
as shown by cDNA analysis in family V, and explains
reduced penetrance of the disorder when the condition
is inherited from the mother.
Loss of Imprinting in Family S
Interestingly, the affected daughter of family S showed
biallelic expression of the SGCE gene, probably because
of loss of imprinting (LOI). Potential reasons for LOI are
removal of DMRs or mutations in regions critical for
regulation of imprinting (Ohta et al. 1999). Although dif-
ferential methylationwas observed in the promoter region
in the affected daughter of family S, we identified several
clones (9/32) with an incomplete methylation pattern,
which is highly unlikely to represent an artifact. Interest-
ingly, hypomethylated alleles were also identified in the
mother but not in the father. Therefore, we assumed that
all completely unmethylated alleles were inherited from
the father and that maternal alleles were hypomethylated
or completely methylated, in the sense of a methylation
mosaic. It remains to be investigated whether the partial
loss of methylation in the regions studied leads to the
biallelic expression in the index patient of family S. It is
conceivable that biallelic expression also occurs in the
mother; however, this could not be investigated, because
of the lack of sequence alterations in the transcribed re-
gion. The cause for the occurrence of hypomethylation
in family S remains to be elucidated and will be further
studied. It is possible that there is a mutation in a cis-
acting regulating element necessary for imprinting of the
SGCE chromosomal region in family S.
Interestingly, alterations in the imprinting pattern that
coincide with expression of the maternal allele seem to
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Table 5
Results of Sequencing of Cloned PCR Products after Bisulfite Conversion,



















II.2 5 14 5 24
I.1 8 6 10 24
I.2 5 6 0 11
Family R:
II.1 5 5 0 10
occur in a considerable percentage of individuals.Analysis
of published pedigrees identified at least 4 of 62 patients
(6%) who inherited the disease from their mother and at
least three asymptomatic carriers who inherited the mu-
tated allele from their father (Zimprich et al. 2001). Re-
markably, a weak expression of the maternal allele was
also observed in mice (Piras et al. 2000). It remains to be
investigated how frequently biallelic expression of the
gene occurs in humans.
On the basis of our clinical data, there was no obvious
phenotypic difference between the affected individuals
of families S and V, in spite of their different SGCE
expression patterns. Coexpression of the mutated and
wild-type allele in the affected daughter of family S sug-
gests that the former confers a dominant-negative effect
or a dominant gain of function.
In conclusion, we provide molecular evidence for pa-
ternal expression of the human SGCE gene caused by
a maternal imprinting mechanism, explaining reduced
penetrance. We show biallelic expression of the SGCE
gene in one affected individual, suggestive of LOI and
possibly related to loss of methylation at several CpG
dinucleotides.
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